State Street Corporation 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 07:52 am Sale | 2024-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,326,158 4.900% | -303,508 (-18.62%) | Filing |
| 2024-01-25 07:48 am Sale | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,629,666 6.100% | -38,259 (-2.29%) | Filing |
| 2023-10-10 11:20 am Sale | 2023-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,667,925 6.270% | -589,921 (-26.13%) | Filing |
| 2023-02-08 09:52 am Sale | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 2,257,846 8.500% | -960,111 (-29.84%) | Filing |
| 2022-04-11 1:47 pm Purchase | 2022-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 3,217,957 12.200% | 1,161,883 (+56.51%) | Filing |
| 2022-02-11 09:40 am Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 2,056,074 7.800% | 2,056,074 (New Position) | Filing |